UNLIMITED TURBO SHORT - ABBOTT LABORATORIES Stock

Certificat

DE000PH40XK5

Delayed Deutsche Boerse AG 09:20:15 2024-05-27 am EDT
3.29 EUR +1.23% Intraday chart for UNLIMITED TURBO SHORT - ABBOTT LABORATORIES
Current month+5.18%
1 month+8.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-27 3.29 +1.23%
24-05-24 3.25 +1.56%
24-05-23 3.2 +0.63%
24-05-22 3.18 -4.50%
24-05-21 3.33 +0.91%

Delayed Quote Deutsche Boerse AG

Last update May 27, 2024 at 09:20 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PH40XK
ISINDE000PH40XK5
Date issued 2021-09-13
Strike 138.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.04
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.99
Lowest since issue 0.56
Spread 0.04
Spread %1.20%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104 USD
Average target price
125.7 USD
Spread / Average Target
+20.92%
Consensus